Effects of selective and nonselective beta-blockade on 24-h ambulatory blood pressure under hypobaric hypoxia at altitude

Journal of Hypertension

Volumn 29, Issue 2, 2011, Pages 380-387

  Bilo, Grzegorz ^a   Caldara, Gianluca ^a   Styczkiewicz, Katarzyna ^c   Revera, Miriam ^a   Lombardi, Carolina ^a   Giglio, Alessia ^a   Zambon, Antonella ^b   Corrao, Giovanni ^b   Faini, Andrea ^a   Valentini, Mariaconsuelo ^a   Mancia, Giuseppe ^a   Parati, Gianfranco ^a,b  

^a ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

^c JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

ambulatory blood pressure monitoring; beta blockers; high altitude; hypoxia

Indexed keywords

CARVEDILOL; NEBIVOLOL;

ADULT; ADVERSE SYMPTOMS SCORE; ALTITUDE; ARTICLE; BLOOD PRESSURE MONITORING; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAYTIME SOMNOLENCE; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; DRUG TOLERABILITY; DYSPNEA; EXERCISE; FATIGUE; FEMALE; HEADACHE; HEART RATE; HUMAN; HUMAN EXPERIMENT; HYPOBARISM; HYPOXIA; LAKE LOUISE SCORE; MALE; MENTAL CONCENTRATION; NAUSEA; NORMAL HUMAN; OXYGEN SATURATION; PERIPHERAL EDEMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SIDE EFFECT; VOMITING; WEAKNESS;

EID: 78651317464     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3283409014     Document Type: Article

References (31)

1. Hainsworth R, Drinkhill MJ. Cardiovascular adjustments for life at high altitude. Respir Physiol Neurobiol 2007; 158:204-211.
2. Mieske K, Flaherty G, O'Brien T. Journeys to high altitude: risks and recommendations for travelers with preexisting medical conditions. J Travel Med 2010; 17:48-62.
3. Duplain H, Vollenweider L, Delabays A, Nicod P, Bartsch P, Scherrer U. Augmented sympathetic activation during short-term hypoxia and highaltitude exposure in subjects susceptible to high-altitude pulmonary edema. Circulation 1999; 99:1713-1718.
4. Hansen J, Sander M. Sympathetic neural overactivity in healthy humans after prolonged exposure to hypobaric hypoxia. J Physiol 2003; 546:921-929.
5. Bä rtsch P, Gibbs JS. Effect of altitude on the heart and the lungs. Circulation 2007;116: 2191-2202.
6. Higgins JP, Tuttle T, Higgins JA. Altitude and the heart: is going high safe for your cardiac patient? Am Heart J 2010; 159:25-32.
7. Bradley HA, Wiysonge CS, Volmink JA, Mayosi BM, Opie LH. How strong is the evidence for use of beta-blockers as first-line therapy for hypertension? Systematic review and meta-analysis. J Hypertens 2006; 24:2131-2141.
8. Packer M, Coats AJ, Fowler MB, Katus HA, Krum H, Mohacsi P, et al. Carvedilol Prospective Randomized Cumulative Survival Study Group: effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001; 344:1651-1658.
9. Flather MD, Shibata MC, Coats AJ, Van Veldhuisen DJ, Parkhomenko A, Borbola J, et al., SENIORS Investigators. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J 2005; 26:215-225.
10. Manrique C, Giles TD, Ferdinand KC, Sowers JR. J Realities of newer betablockers for the management of hypertension. Clin Hypertens (Greenwich) 2009; 11:369-375.
11. Pedersen ME, Cockcroft JR. The vasodilatory beta-blockers. Curr Hypertens Rep 2007; 9:269-277.
12. Agostoni P, Contini M, Cattadori G, Apostolo A, Sciomer S, Bussotti M, et al. Lung function with carvedilol and bisoprolol in chronic heart failure: is beta selectivity relevant? Eur J Heart Fail 2007; 9:827-833.
13. Lombardo RM, Reina C, Abrignani MG, Rizzo PA, Braschi A, De Castro S. Effects of nebivolol versus carvedilol on left ventricular function in patients with chronic heart failure and reduced left ventricular systolic function. Am J Cardiovasc Drugs 2006; 6:259-263.
14. The Lake Louise Consensus on the Definition and Quantification of Altitude Illness. In Sutton JR, Coates G, Houston CS, editors. Hypoxia and mountain medicine. Burlington, Vermont: Queen City Printers; 1992.
15. Fagard R, Brguljan J, Thijs L, Staessen J. Prediction of the actual awake and asleep blood pressures by various methods of 24 h pressure analysis. J Hypertens 1996; 14:557-563.
16. Napoli AM, Milzman DP, Damergis JA, Machan J. Physiologic affects of altitude on recreational climbers. Am J Emer Med 2009; 27:1081-1084.
17. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a new and powerful approach to multiple testing. JRSS B 1995; 57:289-300.
18. Lee J, Herzog TA, Meade CD, Webb MW, Brandon TH. The use of GEE for analyzing longitudinal binomial data: a primer using data from a tobacco intervention. Addict Behav 2007; 32:187-193.
19. Parati G, Bilo G, Mancia G. Prognostic and diagnostic value of ambulatory blood pressure monitoring (Ch. 27). In Oparil S, Weber MA, editors. Hypertension. Companion to Brenner & Rector's the kidney. Philadelphia: Elsevier Saunders; 2005.
20. Barthé lémy JC, Lacour JR, Roche F, Gosse P, Cristol C, Fé asson L, et al. Elevated nocturnal blood pressure assessed by ambulatory automatic monitoring during a stay at high altitude. Eur J Appl Physiol Occup Physiol. 1995; 70: 258-262.
21. De Gaudemaris R, Jalbert M, Isnard E, Flores JL, Siché JP, Perdrix A, et al. Role of ambulatory blood pressure measurement in the evaluation of the cardiovascular load in high altitude workers. Arch Mal Coeur Vaiss 1991; 84:1143-1148.
22. Veglio M, Maule S, Cametti G, Cogo A, Lussiana L, Madrigale G, Pecchio O. The effects of exposure to moderate altitude on cardiovascular autonomic function in normal subjects. Clin Auton Res 1999; 9:123-127.
23. Wolfel EE, Selland MA, Mazzeo RS, Reeves JT. Systemic hypertension at 4300m is related to sympatoadrenal activity. J Appl Physiol 1994; 76:1643-1650.
24. Gupta S, Wright HM. Nebivolol: a highly selective beta1-adrenergic receptor blocker that causes vasodilation by increasing nitric oxide. Cardiovasc Ther 2008; 26:189-202.
25. Busch T, Bä rtsch P, Pappert D, Grü nig E, Hildebrandt W, Elser H, et al. Hypoxia decreases exhaled nitric oxide in mountaineers susceptible to high-altitude pulmonary edema. Am J Respir Crit Care Med 2001; 163:368-373.
26. Scherrer U, Vollenweider L, Delabays A, Savcic M, Eichenberger U, Kleger GR, et al. Inhaled nitric oxide for high-altitude pulmonary edema. N Engl J Med 1996; 334:624-629.
27. Valentini M, Revera M, Caldara G, Gregorini F, Bilo G, Savia G, et al. Effects of selective and nonselective betablockers on exercise performance under hypobaric hypoxia at high altitude. J Hypertens 2008; 26 (Suppl 1):S270.
28. Agostoni P, Contini M, Magini A, Apostolo A, Cattadori G, Bussotti M, et al. Carvedilol reduces exercise-induced hyperventilation: a benefit in normoxia and a problem with hypoxia. Eur J Heart Fail 2006; 8:729-735.
29. Van Bortel LM, Bulpitt CJ, Fici F. Quality of life and antihypertensive effect with nebivolol and losartan. Am J Hypertens 2005; 18:1060-1066.
30. Ambrosioni E, Borghi C. Tolerability of nebivolol in head-to-head clinical trials versus other cardioselective b-blockers in the treatment of hypertension: a meta-analysis. High Blood Pres Card Prev 2005; 12:27-35.
31. Parati G, Bilo G, Modesti PA, Agostoni P, Savia G, Caldara G, et al. on behalf of HIGHCARE Team. Accuracy of different types of blood pressure measuring devices at high and very high altitude: evidence from the HIGHCARE 2008 project. J Hypertens 2009; 27 (Suppl 4):S171.